Dyne is eyeing an accelerated approval filing for DYNE-251 in early 2026 that would pit the asset against Sarepta’s Exondys ...
The defective proteins are called Amyloid‑beta (Aβ) toxic oligomers. The test from AltPep is called the Soluble Oligomer Binding Assay (SOBA‑AD). The research was published Thursday in the ...